Home › Forums › Main Forum › FixHepC Admin › Sof/Dac 2018 guidelines for treatment of G3

Viewing 5 posts - 1 through 5 (of 5 total)
  • Author
    Posts
  • 14 April 2018 at 10:23 am #27828
    Avatar photorightsaidfred
    • Topics: 8
    • Replies: 86
    • Total: 94
    • Guardian Angel
    • ★★★★★
    @rightsaidfred

    Hello All,

    I have just read through the new EASL guidelines and found that the Sof/Dac combo is no longer being recommended for G3. In his blog Greg Jeffrys claims that the real world results for this treatment were not as good as the trial results with SVR obtained in 80% of cases after 12 weeks and 90% after 24 weeks.

    Well it worked for me so I’m not complaining but would anyone like to comment?

    RSF

    G3a. Probably infected 40 years ago.
    Diagnosed July 2015
    7/7/2015: ALP 69, ALT 209, WBC 5.8, VL 40,000. Fibroscan 9.5 Kpa.
    Commenced treatment Sof/Dac (Natco Pharma) 24 wks in Feb 16
    VL UND @ 4 wks, 12 wks

    EOT 6/7/16
    SVR 12
    SVR 24

    PHEW! Thank you so much Dr James, Monkmeds and all at Fixhepc

    14 April 2018 at 11:50 am #27829
    dope-on-a-rope.jpgDr James
    • Guardian Angel
    • ★★★★★
    @fixhepc

    Hello RSF,

    You can read the full version of the guidelines here: http://www.journal-of-hepatology.eu/article/S0168-8278(18)31968-8/pdf which still contain mention of Daclatasvir.

    The practical reality is that with branded Daklinza having a $50,000 list and branded Sovaldi having a $84,000 list that branded Epclusa with a list of $75,000 makes more sense.

    In the world of generics it’s a different story. Still, it’s sad to see the change.

    YMMV

    14 April 2018 at 12:48 pm #27830
    Avatar photorohcvfighter
    • Guardian Angel
    • ★★★★★
    @rohcvfighter

    Perhaps a little bit off-topic, but I think it is the first time when we may see a clear message in the Easl journal that generics provide similar results as original compounds:

    Licensed generic drugs and drugs agreed with the Medicines Patent Pool have been shown to generate similar results to the original compounds. The presence of the drug at the appropriate dosage must be verified by the provider and guaranteed
    to the prescriber and patient. Indeed, effective and safe generics are a crucial resource in resource-limited countries.

    Cheers
    RHF

    In fiecare an HCV ucide peste 500000 oameni.Medicamentele generice pentru hepatita C functioneaza. Nu deveni statistica! Cauta pe Google “medicamente generice pentru hepatita C”.
    HCV kills more than 500000 people every year. HCV generic drugs work. Don’t become a statistic.
    By sharing this Youtube video you might save someone’s life!
    My TX: HEPCVIR-L[generic Harvoni]-India
    SVR52 achieved

    15 April 2018 at 2:33 am #27833
    Avatar photosabrecat
    • Guardian Angel
    • ★★★★★
    @sabrecat

    Hi RSF,

    Sof Dac did not get me over the line first time around though it made me feel better while taking it.

    Adding the dreaded Ribavirin second time round made the difference – I hope still SVR as the next blood test is in June. Have to add my liver had seen better days as well.

    Jeff

    8 May 2018 at 7:46 am #27965
    Avatar photoVororo
    • Guardian Angel
    • ★★★★★
    @vororo

    Hi RSF,

    I had 12 wks of Sof/Doc for GT3, and it seemed to work: SVR at 16 wks. But about 18 months later I found that I had relapsed, so I was probably in the wrong end of the 90% at 24 wks category. Because I felt absolutely fine after 1 year, I did not bother getting a final VL test. With hindsight, this was a mistake.

    With all the success stories here, it now seems like overkill to do a lot of testing while on treatment, but doing 12, 24 and 48 week post-tx tests would still be wise…

    Oor Wullie

    Diagnosed Jan 2015: GT3, A0+F0/F1. Fatigue + Brain-Fog.
    Started Sof+Dac from fixHepC 10-Nov-2015. NO sides.
    Pre-Tx: AST 82, ALT 133, Viral Load 1 900 000.
    Week4: AST 47, ALT 58. VL < 15 (unquantifiable). Week12 (EOT): AST 30, ALT 26, VL UND Week16 (EOT+4): AST 32, ALT 28, GGT 24, VL UND Week28 (EOT+16): AST 26, ALT 22, GGT 24, VL UND Ever grateful to Dr James. Relapsed somewhere after all that... Bummer! Jan 2018: VL 63 000 (still GT3).

  • Author
    Posts
Viewing 5 posts - 1 through 5 (of 5 total)
  • You must be logged in to reply to this topic.